In vivo veritas: The search for TB drug targets goes live

Nature Medicine

Volumn 6, Issue 12, 2000, Pages 1330-1333

  McKinney, J D ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

CLINICAL PRACTICE; DISEASE CARRIER; EPIDEMIC; ERADICATION THERAPY; HUMAN; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; REVIEW; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CARRIER STATE; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, MICROBIAL; LUNG; MYCOBACTERIUM TUBERCULOSIS; RECURRENCE; TUBERCULOSIS, PULMONARY;

EID: 0034528573     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/82142     Document Type: Review

References (43)

1. The global epidemic of tuberculosis: A World Health Organization perspective
2. Address in pathology on chemotherapeutics: Scientific principles, methods, and results
3. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug
4. Distribution and excretion of radioactive isoniazid in tuberculosis patients
5. Genetically determined variability in acetylation and oxidation. Therapeutic implications
6. Ineffectiveness of isoniazid in modifying the phenomenon of microbial persistence
7. The early bactericidal activity of drugs in patients with pulmonary tuberculosis
8. Basic mechanisms of chemotherapy
9. Antibiotic tolerance among clinical isolates of bacteria
10. The treated pulmonary lesion and its tubercle bacillus. The death and resurrection
11. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro
12. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase
13. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis
14. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family
15. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene
16. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis
17. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice
18. A parallel intraphagosomal survival strategy shared by Mycobacterium tuberculosis and Salmonella enterica
19. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages
20. Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor
21. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine
22. Attenuation of and protection by a leucine auxotrophic mutant of Mycobacterium tuberculosis
23. Construction and characterization of a Mycobacterium tuberculosis mutant lacking the alternate sigma factor gene, sigF
24. Deregulation of the Hsp70 heat shock response results in reduced survival of Mycobacterium tuberculosis in the chronic phase of infection
25. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine
26. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis
27. The stringent response of Mycobacterium tuberculosis is required for long-term survival
28. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
29. Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): The effect of isoniazid on gene expression in Mycobacterium tuberculosis
30. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization
31. Present aspects of bacterial resistance in tuberculosis
32. inhA, A gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis
33. Inhibition of a Mycobacterium tuberculosis β-ketoacyl ACP synthase by isoniazid
34. Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis
35. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol
36. Susceptibility of mycobacterial D-alanyl-D-alanine synthetase to D-cycloserine
37. Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis
38. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
39. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: Alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot
40. The fluorocluinolones as antituberculous agents
41. Cloning and expression of Mycobacterium tuberculosis and Mycobacterium leprae dihydropteroate synthase in Escherichia coli